Hospira, Inc., a Pfizer company, is voluntarily recalling one lot of 25% Dextrose Injection, USP, (Infant) pre-filled syringe to the hospital/user level due to the presence of particulate matter, identified as human hair, found within an internal sample syringe.
WSOC
/cloudfront-us-east-1.images.arcpublishing.com/cmg/LH3JSJEF3VBLRJLJQESEAG34AM.png)
:quality(70)/cloudfront-us-east-1.images.arcpublishing.com/cmg/INIPJDENXRDZJDZJH25FT7D76U.png)
:quality(70)/cloudfront-us-east-1.images.arcpublishing.com/cmg/SWNKG6TR5ZDIFJHRE3MIO7Y6QE.jpeg)
:quality(70)/cloudfront-us-east-1.images.arcpublishing.com/cmg/TZXO4QLA7ZDEVNMPB3MVVI7ZJY.png)
:quality(70)/cloudfront-us-east-1.images.arcpublishing.com/cmg/TZFNRJK3UZCNDLRYME4GGG22UA.png)
:quality(70)/cloudfront-us-east-1.images.arcpublishing.com/cmg/SNLWZBPQR5E3PDESM2GSZKRN3Y.jpeg)